Sudarshan Pharma Incorporates Wholly-Owned Subsidiary in USA for Global Market Penetration
Sudarshan Pharma Industries Ltd has expanded its international footprint by incorporating a wholly-owned subsidiary in the United States of America. The new entity, named Sudarshan Industries Inc. (Sudarshan USA), was formally established on Friday, June 5, 2026. This move solidifies the company's commitment to enlarging its customer base within the American market.The parent company invested in the new subsidiary through the subscription of shares and acquisition of full control. Sudarshan Pharma committed to 1,00,00,000 shares of US $0.00001 each of Sudarshan USA. This investment aggregated to US $100, equivalent to approximately Rs. 9,600/-.
Sudarshan Industries Inc. is established with the comprehensive objective to engage in all aspects of the pharmaceutical trade and production business. Its scope includes purchasing, selling, manufacturing, processing, importing, exporting, promoting, developing, wholesale, and/or retail trading across a wide range of products. These goods encompass pharmaceuticals, antibiotics, drugs, medicines, biologicals, neutraceuticals, healthcare items, Ayurvedic and dietary supplement products, medicinal preparations, vaccines, Active Pharmaceutical Ingredients (APIs), and other allied chemical compounds.
The establishment of the subsidiary is backed by the appointment of Mr. Sachin Mehta as the First Director of Sudarshan USA.
Key details regarding the incorporation and transaction are summarized below:
| Detail | Information |
|---|---|
| Name of Entity | Sudarshan Industries Inc. (Sudarshan USA) |
| Date of Incorporation | June 5, 2026 |
| Business Scope | Trading and manufacturing in pharmaceuticals, antibiotics, drugs, biologicals, neutraceuticals, and allied chemical products across the globe. |
| Shareholding Acquired | 100.00% |
| Number of Shares Acquired | 1,00,00,000 shares of US $0.00001 each |
| Cost of Acquisition | US $100 (approx. Rs. 9,600/-) |
Stock Price Movement
Sudarshan Pharma Industries Ltd settled at ₹35.00 after the close of trade today, finishing the day completely flat with a 0.00% change. The shares experienced intraday volatility, moving within a range defined by a low of ₹34.99 and a high of ₹35.40.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.